FGF19 and colitis: In this study, FGF19-M52, a variant of the FGF19 protein was applied and demonstrated to maintain the intestinal barrier, inhibit inflammatory immune response (reduced macrophages recruitment and pro-inflammatory cytokines) and regulate the gut microbial community, leading to alleviation of colitis in a FXR-dependent manner.